MOODMAPS v1
Research type
Research Study
Full title
The MOODMAPS study: evaluating the identification and management of depression in people living with advance kidney disease across different UK renal services, a mixed-method study
IRAS ID
290849
Contact name
Joseph Chilcot
Contact email
Sponsor organisation
King’s College London
Duration of Study in the UK
0 years, 7 months, 31 days
Research summary
Chronic kidney disease (CKD) is a long-term condition (LTC) in which a person’s kidneys do not work effectively. Depression is common among people with CKD compared to the general population and is linked with poorer physical health, lower quality of life and patients may even die younger, compared to people with CKD who are not depressed. Currently little is known about how best to treat depression in CKD patients. There are national guidelines to guide the clinical management of people with long-term conditions and depression. However, we do not know how these guidelines are used, or whether they are helpful supporting the management of depression in people with CKD.\nWe aim to better understand how adults with CKD and depression are identified and treated, and to use this information to design effective management pathways. \nBased on a questionnaire sent to renal services across the UK we will select six-eight sites which are varied in the level of support available to people with CKD and depression and their location across the UK. These ‘case studies’ will involve reviewing local policies, speaking to staff, patients, carers and other relevant health professionals (including GPs and specialist staff). Patients will also complete a questionnaire to measure the level of mental health need and access. We will also recruit from groups that are underrepresented in research (patients from minority ethnic groups and those with lower literacy levels) to discuss their specific needs and experiences of mental health support.\nThis case study approach should provide a rich description of the treatment and care pathways of adults with CKD and depression across the UK and will be used to make recommendations for an effective pathway of care for people with CKD and depression.\nThis research is funded by Kidney Research UK and the Stoneygate Trust (reference number: KS_RP_006_20190919).
REC name
South Central - Oxford B Research Ethics Committee
REC reference
22/SC/0315
Date of REC Opinion
12 Oct 2022
REC opinion
Further Information Favourable Opinion